
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-manuscript.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F39205000039875D61C236.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3731129/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731129/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Clinical cancer research : an official journal of the American Association for Cancer Research" /><meta name="citation_title" content="Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis" /><meta name="citation_author" content="Dimple Chakravarty" /><meta name="citation_author_institution" content="Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio" /><meta name="citation_author" content="Sudipa Saha Roy" /><meta name="citation_author_institution" content="Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio" /><meta name="citation_author" content="Challa Ram Babu" /><meta name="citation_author_institution" content="Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio" /><meta name="citation_author" content="Rajasekhar Dandamudi" /><meta name="citation_author_institution" content="Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio" /><meta name="citation_author" content="Tyler J. Curiel" /><meta name="citation_author_institution" content="Department of Med/Hematology &#x00026; Med Oncology and CTRC at The UT Health Science Center, San Antonio" /><meta name="citation_author" content="Pablo Vivas-Mejia" /><meta name="citation_author_institution" content="Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico" /><meta name="citation_author" content="Gabriel Lopez-Berestein" /><meta name="citation_author_institution" content="Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author_institution" content="Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author_institution" content="Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author_institution" content="Department of Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author" content="Anil K. Sood" /><meta name="citation_author_institution" content="Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author_institution" content="Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author_institution" content="Department of Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas" /><meta name="citation_author" content="Ratna K. Vadlamudi" /><meta name="citation_author_institution" content="Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio" /><meta name="citation_publication_date" content="2011/04/04" /><meta name="citation_issue" content="8" /><meta name="citation_volume" content="17" /><meta name="citation_firstpage" content="2250" /><meta name="citation_doi" content="10.1158/1078-0432.CCR-10-2718" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3731129/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3731129/" /><meta name="citation_pmid" content="21421858" /><meta name="DC.Title" content="Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Dimple Chakravarty" /><meta name="DC.Contributor" content="Sudipa Saha Roy" /><meta name="DC.Contributor" content="Challa Ram Babu" /><meta name="DC.Contributor" content="Rajasekhar Dandamudi" /><meta name="DC.Contributor" content="Tyler J. Curiel" /><meta name="DC.Contributor" content="Pablo Vivas-Mejia" /><meta name="DC.Contributor" content="Gabriel Lopez-Berestein" /><meta name="DC.Contributor" content="Anil K. Sood" /><meta name="DC.Contributor" content="Ratna K. Vadlamudi" /><meta name="DC.Date" content="2011 Apr 15" /><meta name="DC.Identifier" content="10.1158/1078-0432.CCR-10-2718" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis" /><meta property="og:type" content="article" /><meta property="og:description" content="Ovarian cancer remains a major threat to women's health, partly due to difficulty in early diagnosis and development of metastases. A critical need exists to identify novel targets that curb the progression and metastasis of ovarian cancer. In this study ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731129/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3731129/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3731129
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3731129/pdf/nihms343635.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3731129/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3731129/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3731129" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="9gXCx57b5FI6ndFADSJGHcd7lcaFKQ9WRrgImMOBUJSZSoTjGBsGsc9l4sSe5WtU">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F&amp;text=Therapeutic%20Targeting%20of%20PELP1%20Prevents%20Ovarian%20Cancer%20Growth%20and%20Metastasis" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731129/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/21421858/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/21421858/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3731129/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3731129
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-nihpa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Clin Cancer Res.</span> Author manuscript; available in PMC 2013 Aug 1.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21421858" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Clin Cancer Res. 2011 Apr 15; 17(8): 2250–2259. </a></div><span class="fm-vol-iss-date">Published online 2011 Mar 18. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1158%2F1078-0432.CCR-10-2718" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/1078-0432.CCR-10-2718</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3731129</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS343635</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21421858">21421858</a></div></div></div><h1 class="content-title">Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chakravarty%20D%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566321881408" co-class="co-affbox">Dimple Chakravarty</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Roy%20SS%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566310751520" co-class="co-affbox">Sudipa Saha Roy</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Babu%20CR%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566316628160" co-class="co-affbox">Challa Ram Babu</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dandamudi%20R%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566316626624" co-class="co-affbox">Rajasekhar Dandamudi</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Curiel%20TJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566320148816" co-class="co-affbox">Tyler J. Curiel</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vivas-Mejia%20P%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566320146832" co-class="co-affbox">Pablo Vivas-Mejia</a>,<sup>7</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lopez-Berestein%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566321975808" co-class="co-affbox">Gabriel Lopez-Berestein</a>,<sup>3,</sup><sup>4,</sup><sup>5,</sup><sup>6</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sood%20AK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566308687168" co-class="co-affbox">Anil K. Sood</a>,<sup>4,</sup><sup>5,</sup><sup>6</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vadlamudi%20RK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140566310092672" co-class="co-affbox">Ratna K. Vadlamudi</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140566321881408"><h3 class="no_margin">Dimple Chakravarty</h3><p><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chakravarty%20D%5BAuthor%5D">Dimple Chakravarty</a></div></div><div id="_co_idm140566310751520"><h3 class="no_margin">Sudipa Saha Roy</h3><p><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Roy%20SS%5BAuthor%5D">Sudipa Saha Roy</a></div></div><div id="_co_idm140566316628160"><h3 class="no_margin">Challa Ram Babu</h3><p><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Babu%20CR%5BAuthor%5D">Challa Ram Babu</a></div></div><div id="_co_idm140566316626624"><h3 class="no_margin">Rajasekhar Dandamudi</h3><p><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dandamudi%20R%5BAuthor%5D">Rajasekhar Dandamudi</a></div></div><div id="_co_idm140566320148816"><h3 class="no_margin">Tyler J. Curiel</h3><p><sup>2</sup>Department of Med/Hematology &#x00026; Med Oncology and CTRC at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Curiel%20TJ%5BAuthor%5D">Tyler J. Curiel</a></div></div><div id="_co_idm140566320146832"><h3 class="no_margin">Pablo Vivas-Mejia</h3><p><sup>7</sup>Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vivas-Mejia%20P%5BAuthor%5D">Pablo Vivas-Mejia</a></div></div><div id="_co_idm140566321975808"><h3 class="no_margin">Gabriel Lopez-Berestein</h3><p><sup>3</sup>Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas</p><p><sup>4</sup>Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas</p><p><sup>5</sup>Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas</p><p><sup>6</sup>Department of Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lopez-Berestein%20G%5BAuthor%5D">Gabriel Lopez-Berestein</a></div></div><div id="_co_idm140566308687168"><h3 class="no_margin">Anil K. Sood</h3><p><sup>4</sup>Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas</p><p><sup>5</sup>Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas</p><p><sup>6</sup>Department of Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sood%20AK%5BAuthor%5D">Anil K. Sood</a></div></div><div id="_co_idm140566310092672"><h3 class="no_margin">Ratna K. Vadlamudi</h3><p><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vadlamudi%20RK%5BAuthor%5D">Ratna K. Vadlamudi</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140566320608112_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140566320608112_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140566320608112_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Department of Obstetrics and Gynecology at The UT Health Science Center, San Antonio</div><div class="fm-affl" id="A2"><sup>2</sup>Department of Med/Hematology &#x00026; Med Oncology and CTRC at The UT Health Science Center, San Antonio</div><div class="fm-affl" id="A3"><sup>3</sup>Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas</div><div class="fm-affl" id="A4"><sup>4</sup>Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas</div><div class="fm-affl" id="A5"><sup>5</sup>Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas</div><div class="fm-affl" id="A6"><sup>6</sup>Department of Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas</div><div class="fm-affl" id="A7"><sup>7</sup>Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico</div><div id="FN1">Corresponding Author: Ratna K. Vadlamudi, Division of Reproductive Research, Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7836, San Antonio, TX 78229. Phone: (210) 567-4930; Fax: (210) 567-4958; <a href="mailto:dev@null" data-email="ude.ascshtu@idumaldav" class="oemail">ude.ascshtu@idumaldav</a></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140566320608112_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21421858" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Clin Cancer Res</a></div><div><strong>This article has been corrected. </strong>See the correction  in  volume 19 on page 1305.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 19% 3px;"></div></div></div><div class="sec"></div><div id="abstract-a.g.b.x" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.g.b.xtitle">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Purpose</h3><p id="P1" class="p p-first-last">Ovarian cancer remains a major threat to women's health, partly due to difficulty in early diagnosis and development of metastases. A critical need exists to identify novel targets that curb the progression and metastasis of ovarian cancer. In this study we examined whether the nuclear receptor coregulator PELP1 (proline-, glutamic acid-, leucine-rich protein-1) contributes to progression and metastatic potential of ovarian cancer cells and determined whether blocking of the PELP1 signaling axis had a therapeutic effect.</p></div><div id="S2" class="sec"><h3 id="S2title">Experimental Design</h3><p id="P2" class="p p-first-last">Ovarian cancer cells stably expressing PELP1-shRNA (short hairpin RNA) were established. Fluorescent microscopy, Boyden chamber, invasion assays, wound healing, and zymography assays were performed to examine the role of PELP1 in metastasis. Expression analysis of the model cells was conducted using tumor metastasis microarray to identify PELP1 Target genes. Therapeutic potential of PELP1-siRNA <em>in vivo</em> was determined using a nanoliposomal formulation of PELP1-siRNA-DOPC (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine) administered systemically in a xenograft model.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">PELP1 knockdown caused cytoskeletal defects and significantly affected the migratory potential of ovarian cancer cells. Microarray analysis revealed that PELP1 affected the expression of selective genes involved in metastasis including <em>Myc</em>, <em>MTA1</em>, <em>MMP2</em>, and <em>MMP9</em>. Zymography analysis confirmed that PELP1 knockdown caused a decrease in the activation of matrix metalloproteases (MMP) 2 and MMP9. Compared with control siRNA-DOPC-treated mice, animals injected with PELP1-siRNA-DOPC had 54% fewer metastatic tumor nodules, exhibited a 51% reduction in tumor growth and an 84% reduction in ascites volume.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusion</h3><p id="P4" class="p p-first-last">The results suggest that PELP1 signaling axis is a potential druggable target and liposomal PELP1-siRNA-DOPC could be used as a novel drug to prevent or treat ovarian metastasis.</p></div></div></div><div id="S5" class="tsec sec"><h2 class="head no_bottom_margin" id="S5title">Introduction</h2><p id="P5" class="p p-first">Ovarian carcinoma continues to be the leading cause of death due to gynecologic malignancy in the United States because it is usually diagnosed in the advanced stage of the disease (<a href="#R1" rid="R1" class=" bibr popnode">1</a>, <a href="#R2" rid="R2" class=" bibr popnode">2</a>). The standard treatment for epithelial ovarian cancer remains surgical debulking and chemotherapy with a platinum and taxane agent. Although many patients with disseminated tumors respond initially to standard combinations of surgical and cytotoxic therapy, nearly 90% of them develop recurrence (<a href="#R3" rid="R3" class=" bibr popnode">3</a>). A widely recognized behavior of ovarian cancer is its ability to migrate and seed the peritoneal cavity with nests of tumor cells and the formation of ascites (<a href="#R4" rid="R4" class=" bibr popnode">4</a>). The transition from early- to advanced-stage ovarian cancer is a critical determinant of survival; yet, little is known about the molecules that contribute to progression and metastasis of ovarian tumors.</p><p id="P6">The biological functions of hormones are mediated by nuclear receptors (NR) and several recent studies demonstrated the presence of NRs in about 70% of ovarian epithelial tumors. In the past decade, it has become increasingly clear that the sole existence of NRs is not sufficient for optimal NR function; several coregulatory proteins are also required (<a href="#R5" rid="R5" class=" bibr popnode">5</a>, <a href="#R6" rid="R6" class=" bibr popnode">6</a>). Many coregulatory proteins are present at rate-limiting levels, are shared by many NRs, and have the potential to control the expression of various subsets of genes to regulate cell processes coordinately such as proliferation and metastasis (<a href="#R7" rid="R7" class=" bibr popnode">7</a>). With the enormous potential of coregulators as master regulators, their deregulation is likely to provide the cancer cells an advantage in proliferation, survival, and metastasis (<a href="#R8" rid="R8" class=" bibr popnode">8</a>, <a href="#R9" rid="R9" class=" bibr popnode">9</a>). As a consequence, there is a critical need to identify and understand the physiologic role of master coregulators that promote initiation and progression of ovarian cancer and metastasis.</p><p id="P7">Proline-, glutamic acid-, leucine-rich protein-1 (PELP1; ref. <a href="#R10" rid="R10" class=" bibr popnode">10</a>) is an NR coregulator that interacts with many NRs including estrogen receptor (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). PELP1 is predominantly localized in the nuclear compartment, interacts with histones and histone-modifying enzymes, and thus plays a role in chromatin remodeling for ligand-bound NRs (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). PELP1 promotes cell proliferation by sensitizing cells to G<sub>1</sub>&#x02192;S progression via its interactions with the pRb pathway (<a href="#R12" rid="R12" class=" bibr popnode">12</a>). PELP1 is also unique because it plays important roles in both the genomic (<a href="#R13" rid="R13" class=" bibr popnode">13</a>) and nongenomic actions of the NRs (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). PELP1 is a recently identified proto-oncogene (<a href="#R14" rid="R14" class=" bibr popnode">14</a>). Its expression is deregulated in hormonal-dependent cancers including those of breast, endometrium, and ovaries (<a href="#R15" rid="R15" class=" bibr popnode">15</a>&#x02013;<a href="#R17" rid="R17" class=" bibr popnode">17</a>).</p><p id="P8" class="p p-last">In this study, we investigated whether PELP1 signaling plays a role in ovarian epithelial cancer cell migration and metastasis by silencing PELP1 expression in ovarian cancer cells and in orthotopic models of ovarian cancer. Our findings revealed that PELP1 modulates metastasis of ovarian cancer cells by regulating expression of a number of genes involved in metastasis. Silencing endogenous PELP1 expression via nanoliposomal siRNA targeted to PELP1 (PELP1-siRNA-DOPC) <em>in vivo</em> significantly reduced tumor growth, number of tumor nodules in the peritoneal cavity and ascites volume. Our results suggest that PELP1 plays a critical role in ovarian cancer progression to metastasis and thus represents a novel therapeutic target for curbing ovarian metastasis.</p></div><div id="S6" class="tsec sec"><h2 class="head no_bottom_margin" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Cell cultures and reagents</h3><p id="P9" class="p p-first-last">OVCAR3 and ES2 cells were purchased from the American Type Culture Collection and maintained in RPMI 1640 supplemented with 20% FBS (Hyclone Laboratories Ltd). The derivation of the ovarian cancer cell line SKOV3ip1 has been described (<a href="#R18" rid="R18" class=" bibr popnode">18</a>). These cells were cultured in RPMI 1640 medium supplemented with 15% FBS and 0.1% gentamicin sulfate (Gemini Bioproducts). Nontumorigenic SV40 Tag-immortalized ovarian surface epithelial-derived cells (IOSE-80) were earlier described (<a href="#R19" rid="R19" class=" bibr popnode">19</a>) and cultured in medium 199:MCDB 105 (1:1; Sigma-Aldrich Corp) containing 15% FBS. Antibodies against vinculin were purchased from Sigma Chemical Co. The PELP1 antibody was purchased from Bethyl Laboratories and antibodies for matrix metalloproteases (MMP) 2, H3K9Ac, and H3K9me2 were purchased from Millipore.</p></div><div id="S8" class="sec"><h3 id="S8title">Generation of PELP1-shRNA model cells</h3><p id="P10" class="p p-first-last">Ovarian cancer cells stably expressing PELP1-shRNA (short hairpin RNA) were generated using the FuGENE-6 transfection reagent (Roche) and were selected with G418 selection (500 &#x003bc;g/mL). Pooled clones were used for all the studies. For IOSE cells, electroporation (nucleofection) was used to transfect PELP1 plasmids as previously described (<a href="#R20" rid="R20" class=" bibr popnode">20</a>). The PELP1-specific Sure Silencing shRNA plasmids, catalogue no. KH19454N and control shRNA vector were purchased from SABiosciences. The targeted sequences were PELP1-shRNA1: GGACCAAGGTGTATGCGATAT; PELP1-shRNA2: ATGCTGCTGTCCTC AGAAGAT. The PELP1-shRNA design was based on the GenBank accession number <a id="__tag_1136781417" class="tag_hotlink" href="/nuccore/NM_014389" ref="/nuccore/NM_014389"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_014389","term_id":"1527146932","term_text":"NM_014389"}}</span>NM_014389</a>. Transient knockdown of PELP1 was achieved using On-Target-PlusSMARTpool siRNA (L-004463-00-0050; Thermo-scientific) and by using oligofectamine transfection (Invitrogen).</p></div><div id="S9" class="sec"><h3 id="S9title">Microarray studies</h3><p id="P11" class="p p-first-last">The Human Tumor Metastasis Microarray (Oligo GEArray) was from SABiosciences and contains 113 genes known to be involved in metastasis. Total RNA isolated from OVCAR3 and OVCAR3-PELP1-shRNA cells was used for screening. Probe preparation and hybridization was performed per manufacturer's instructions. Target genes whose expression was differentially regulated (at least 3-fold difference) by PELP1 underexpression were selected and validated using real-time PCR in OVCAR3 and SKOV3ip1 cells. Validated real-time PCR primers were used for validation of PELP1-regulated genes and all primers were purchased from <a href="http://RealTimePrimers.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">RealTimePrimers.com</a>.</p></div><div id="S10" class="sec"><h3 id="S10title">Cell migration, invasion, and MMP reporter gene assays</h3><p id="P12" class="p p-first-last">The cell migration was determined using 8 micromolar pore calorimetric cell migration assay kit (Chemicon) using the manufacturer's protocol. For the cell migration assay, 10<sup>5</sup> cells per 300 &#x003bc;L of serum-free medium were seeded onto the upper chamber and 0.75 mL of complete growth medium containing 10% FBS was added to each well in the lower chamber (<a href="#R21" rid="R21" class=" bibr popnode">21</a>). Invasion assays were performed using BD Biocoat growth factor&#x02013;reduced Matrigel invasion chamber (BD Biosciences) as per manufacturer's protocol. The PGL3-MMP9-Luc promoter plasmid that contains 1,305 bp of proximal promoter region of human MMP9 was received from Dr. Xu (<a href="#R22" rid="R22" class=" bibr popnode">22</a>). The PGL3-MMP2-Luc promoter plasmid that contains 1,659 bp of proximal promoter region of human MMP2 was received from Dr. Benveniste (<a href="#R23" rid="R23" class=" bibr popnode">23</a>). Reporter gene assays were performed by transient transfection using FuGENE6 method (Roche) as described (<a href="#R24" rid="R24" class=" bibr popnode">24</a>). Each transfection was carried out in 6-well plates in triplicate and normalized with &#x003b2;-gal activity and the total protein concentration.</p></div><div id="S11" class="sec"><h3 id="S11title">Gelatin zymography</h3><p id="P13" class="p p-first-last">The culture supernatant of model cells expressing control or PELP1-shRNA was used to determine the enzymatic activity of MMP2 and MMP9 by using SDS-PAGE gelatin zymography as described (<a href="#R25" rid="R25" class=" bibr popnode">25</a>) using Novex Zymogram Gels (Invitrogen). Recombinant MMP2 and MMP9 (R&#x00026;D Systems) were used as positive controls.</p></div><div id="S12" class="sec"><h3 id="S12title">ChIP assays</h3><p id="P14" class="p p-first-last">Chromatin immunoprecipitation (ChIP) assay was done using antibodies specific for PELP1, H3K9Ac, H3K9me2, or isotype rabbit IgG control in SKOV3ip1 cells as described (<a href="#R24" rid="R24" class=" bibr popnode">24</a>). DNA recovered from ChIP or input controls was subjected to real-time quantitative PCR (qPCR) using primers spanning various regions of MMP9 promoter as described (<a href="#R22" rid="R22" class=" bibr popnode">22</a>). Sequences of MMP promoter primers used: A-F: cttcagagccaggcagttct; A-R: agcctctcgtttcatcctca; B-F: taattgggcctggagatttg; B-R: agcctctcgtttcatcctca; C-F: taagacatttgcccgaggtc; C-R: cctctttttccctccctgac; D-F: ggaggtggtgtaagcccttt; and D-R: agggcagaggtgtctgactg. The promoter occupancy was calculated on the basis of the ratio of ChIP/input control.</p></div><div id="S13" class="sec"><h3 id="S13title">Immunofluorescence studies</h3><p id="P15" class="p p-first-last">Confocal microscopy was performed as previously described (<a href="#R21" rid="R21" class=" bibr popnode">21</a>). For these studies, cells were grown on glass cover slips and fixed in 3.7% paraformaldehyde for 15 minutes at room temperature. The fixed cells were then permeabilized with 0.2% TritonX-100 in PBS for 15 minutes followed by blocking with 5% normal goat serum (Sigma) in PBS for 1 hour. The DNA dye 4&#x02032;,6-diamidino-2-phenylindole (Molecular Probes) was used to costain the DNA (blue). The filamentous actin (F-actin) status was analyzed by phalloidin staining (fluorescein isothiocyanate conjugated from Molecular Probes) for 1 hour at room temperature.</p></div><div id="S14" class="sec"><h3 id="S14title">Preparation of liposomal siRNA</h3><p id="P16" class="p p-first-last">For <em>in vivo</em> delivery, PELP1-siRNA was incorporated into 1,2-dioleoyl-<em>sn</em>-glycero-3-phosphatidylcholine (DOPC) nanoliposomes as described previously (<a href="#R26" rid="R26" class=" bibr popnode">26</a>, <a href="#R27" rid="R27" class=" bibr popnode">27</a>). Briefly, siRNA and DOPC were mixed in excess tertiary butanol at a ratio of 1:10 (w/w), respectively. Subsequently, Tween 20 was added to the mixture at the ratio of 1:19 (Tween 20: siRNA-DOPC). The mixture was vortexed and frozen in an acetone/dry ice bath and lyophilized. For <em>in vivo</em> administration, the mixture was hydrated with 0.9% saline to a concentration of 15 &#x003bc;g/mL, and 200 to 250 &#x003bc;L of the mixture was used for each injection. siRNA for preparation of liposomes were purchased from Sigma. The targeted sequences used were: PELP1: 5&#x02032;-ccacagagccugacuccua-3&#x02032; control: 5&#x02032;-uucuccgaacgugucacgu-3&#x02032;.</p></div><div id="S15" class="sec"><h3 id="S15title">Nude mice studies</h3><p id="P17" class="p p-first-last">For <em>in vivo</em> injections, the SKOV3ip1 cells (<a href="#R28" rid="R28" class=" bibr popnode">28</a>) were trypsinized, washed twice with PBS, and reconstituted in serum-free HBSS (Invitrogen) at a concentration of 5 &#x000d7; 10<sup>6</sup> cells/mL, which were then injected intraperitoneally in 5- to 6-week-old female athymic nude mice. To examine the effects of PELP1-siRNA therapy on tumor growth, treatment was initiated 1 week after intraperitoneal injection of tumor cells. Mice were randomly assigned into 2 groups (<em>n</em> = 8 mice per group): (i) control siRNA-DOPC (150 &#x003bc;g/kg i.p. twice weekly) and (ii) PELP1-siRNA-DOPC (150 &#x003bc;g/kg i.p. twice weekly). The mice were monitored daily for adverse affects and the treatment was continued for 27 days. On day 27, mice were euthanized and the total weight, tumor weight, number of metastastic tumor nodules, and volume of ascitic fluid were recorded. Tissue samples were snap frozen for lysate preparation or fixed in formalin for paraffin embedding.</p></div><div id="S16" class="sec"><h3 id="S16title">Immunohistochemistry</h3><p id="P18" class="p p-first-last">Immunohistochemical (IHC) analysis was performed as described (<a href="#R20" rid="R20" class=" bibr popnode">20</a>). Briefly, tumor sections were incubated overnight with the primary antibodies [PELP1 (1:500), MMP9 (1:50)]. The sections were then washed 3 times with 0.05% Tween in PBS for 10 minutes, incubated with secondary antibody for 1 hour, washed 3 times with 0.05% Tween in PBS for 10 minutes, developed with 3,3V-diaminobenzidine-H<sub>2</sub>O<sub>2</sub>, and counterstained with Mayer's hematoxylin. Proliferating cell nuclear antigen (PCNA; 1:100) from Vector Labs was used in conjunction with proper controls, visualized by DAB (3,3&#x02032;-diaminobenzidine) substrate, and counterstained with hematoxylin (Vector Lab, Inc.). Proliferative index was calculated as percentage of PCNA-positive cells in 10 randomly selected microscopic fields at 100&#x000d7; per slide. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) analysis was done using the In situ Cell Death Detection Kit (Roche) as per the manufacturer's protocol and 10 randomly selected microscopic fields in each group were used to calculate the relative ratio of TUNEL-positive cells. MMP9 expression tumors were quantified as the number of positive cells &#x000d7;100/total number of cells counted under 100&#x000d7; magnification in 10 randomly selected areas in each tumor sample.</p></div><div id="S17" class="sec sec-last"><h3 id="S17title">Statistical analysis</h3><p id="P19" class="p p-first-last">Statistical differences among groups were analyzed with either <em>t</em> test or ANOVA as appropriate using SPSS software.</p></div></div><div id="S18" class="tsec sec"><h2 class="head no_bottom_margin" id="S18title">Results</h2><div id="S19" class="sec sec-first"><h3 id="S19title">PELP1-shRNA clones exhibit defects in cytoskeletal reorganization</h3><p id="P20" class="p p-first-last">Recently, we established OVCAR3 model cells that stably express PELP1-shRNA (<a href="#R20" rid="R20" class=" bibr popnode">20</a>). These cells had less growth potential and distinct flat morphology compared with the morphology of OVCAR3 parental or OVCAR3 vector cells. To further explore this phenotypic observation, we generated 2 additional ovarian cancer cells (SKOV3ip1 and ES2) that stably express PELP1-shRNA. These cells had a 70% to 80% decrease in the expression of PELP1 (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1A</span></a>). Interestingly, SKOV3ip1 and ES2 cells expressing PELP1-shRNA also exhibited flat morphology (data not shown). We therefore examined whether the lack of PELP1 expression contributes to cytoskeletal defects in ovarian cancer cells. OVCAR3 (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>) and SKOV3ip1 (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1C</span></a>) control cells as well as PELP1-shRNA expressing cells were serum starved and treated with or without epidermal growth factor (EGF) for 10 minutes, and F-actin status was analyzed by phalloidin staining. Serum-starved control cells exhibited low F-actin structures with peripheral cortical actin, and EGF stimulation promoted increased formation of ruffles and fillopodia (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B and C</span></a>). Interestingly in PELP1 knockdown cells, EGF treatment did not promote formation of fillopodia or ruffles. However, PELP1-shRNA cells had increased accumulation of stress fibers, which is also an indication of less motile cells (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B and C</span></a>). Similar defects in actin reorganization were also seen in ES2 cells expressing PELP1-shRNA were stimulated with either EGF or estrogen (<a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D</span></a>). Collectively, these results suggest that PELP1 signaling plays a role in cytoskeletal reorganization and could be required for optimal actin reorganization in ovarian epithelial cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3731129/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140566310444800"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f1.jpg" src="/pmc/articles/PMC3731129/bin/nihms343635f1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140566310444800"><a target="object" rel="noopener" href="/pmc/articles/PMC3731129/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3731129/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p>PELP1 knockdown promotes defects in actin reorganization of ovarian epithelial cells. A, OVCAR3, SKOV3ip1, ES2 cells untransfected (Untrans), and or stably expressing negative control (NC)-shRNA vector or PELP1-shRNA were lysed and the expression of PELP1 was analyzed by Western blotting. OVCAR3 (B), SKOV3ip1 (C) cells untransfected, and or stably expressing vector or PELP1-shRNA were treated with EGF (100 ng/&#x003bc;L) for 10 minutes. The status of F-actin was analyzed by confocal microscopy. D, ES2 cells untransfected and or stably expressing vector or PELP1-shRNA were treated with EGF (100 ng/&#x003bc;L) or E2 (10<sup>&#x02212;9</sup> mol/L) for 10 minutes. The status of F-actin was analyzed by confocal microscopy.</p></div></div></div></div><div id="S20" class="sec"><h3 id="S20title">PELP1 downregulation affects expression of selective genes involved in metastasis</h3><p id="P21" class="p p-first-last">PELP1 plays a critical role in NR genomic functions via chromatin remodeling and by modulating histone code at the NR target promoters (<a href="#R29" rid="R29" class=" bibr popnode">29</a>). Since PELP1 knockdown cells had defects in cell shape and cytoskeletal reorganization, we examined whether the lack of expression of PELP1 affects the expression of genes involved in cell migration/metastasis by using a focused microarray approach. We used the Human Tumor Metastasis Microarray, which contains 113 genes known to be involved in metastasis including genes involved in cell adhesion, ECM (extracellular matrix) components, cell cycle, cell growth and proliferation, apoptosis, transcription factors and regulators, and other genes related to tumor metastasis. Total RNA isolated from OVCAR3 and OVCAR3-PELP1-shRNA cells was used for the array analysis and the results from this screen suggested that PELP1 downregulation substantially reduced the expression of a number of genes, including <em>MMP2</em>, <em>MMP9</em>, <em>MTA1</em>, <em>Myc</em>, and <em>SMAD2</em>, compared with their expression in control cells (<a href="/pmc/articles/PMC3731129/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a>). We validated the changes seen in the array study by measuring gene expression of the top 5 genes that had significant reduction by performing real-time qPCR on the OVCAR3-PELP1-shRNA cells or control shRNA cells (<a href="/pmc/articles/PMC3731129/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). The changes in the expression of these genes were also independently confirmed in SKOV3ip1 cells expressing PELP1-siRNA that target a different site in PELP1 as compared with PELP1-shRNA targeting site (<a href="/pmc/articles/PMC3731129/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2C</span></a>). These results suggest that PELP1 has potential to modulate expression of genes involved in the cell migration/metastasis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3731129/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140566313104608"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3731129_nihms343635f2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3731129/bin/nihms343635f2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140566313104608"><a target="object" rel="noopener" href="/pmc/articles/PMC3731129/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3731129/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p>PELP1 knockdown affects expression of selective genes involved in metastasis. A, RNA isolated from OVCAR3-shRNA negative control and OVCAR3-PELP1-shRNA expressing cells were hybridized to the human tumor metastasis Oligo GEArray. Changes in the gene expression were analyzed using SABioscience software with actin as a control for normalization. Representative genes downregulated upon PELP1 depletion are shown. B, real-time qPCR validation of the changes in gene expression in OVCAR3 cells stably expressing negative control shRNA or PELP1-shRNA. C, SKOV3ip1 cells were transiently transfected with control or PELP1-specific siRNA and the expression of indicated genes was analyzed real-time qPCR.</p></div></div></div></div><div id="S21" class="sec"><h3 id="S21title">PELP1 expression is needed for optimal activation of MMPs</h3><p id="P22" class="p p-first-last">Since PELP1 downregulation altered expression of MMPs and because MMPs are known to promote cancer progression by enhancing cell growth, migration, invasion, and metastasis of ovarian cancer cells (<a href="#R30" rid="R30" class=" bibr popnode">30</a>, <a href="#R31" rid="R31" class=" bibr popnode">31</a>), we examined whether the reduction in the expression seen in PELP1-shRNA clones translates to lower MMP activity. The activity of MMP2 and MMP9 was determined in SKOV3ip1 and ES2 cells expressing control or PELP1-siRNA by using gelatin zymography. MMP2 and MMP9 activities were lower in PELP1 knockdown cells than in control cells (<a href="/pmc/articles/PMC3731129/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3A</span></a>). To examine the mechanism by which PELP1 regulate MMP2 and MMP9 expression, we have performed promoter-Luc assays using previously published MMP2 and MMP9 reporter genes (<a href="#R22" rid="R22" class=" bibr popnode">22</a>, <a href="#R23" rid="R23" class=" bibr popnode">23</a>). In both SKOV3ip1 and ES2 model cells, knockdown of PELP1 significantly reduced the MMP2 and MMP9 reporter gene activation (<a href="/pmc/articles/PMC3731129/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3B</span></a>). We examined further to check whether PELP1-mediated regulation of MMPs is due to PELP1 recruitment to the promoter regions of MMPs using a ChIP-based assay. Initially, we have used 4 different primers that recognize various regulatory regions reported to activate MMP9. ChIP results showed that PELP1 is uniquely recruited to the proximal promoter region of MMP9 (<a href="/pmc/articles/PMC3731129/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3C</span></a>) and no recruitment in distal regions was observed. Emerging data implicate that PELP1 associates with acetylases (p300, CBP) and demethylases (KDM1) and participates in epigenetic modifications that are required for optimal transcriptional activation (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). We therefore examined whether PELP1 downregulation affects epigenetic modifications at the MMP9 proximal promoter. ChIP analysis revealed that PELP1 knockdown enhances repressive mark H3K9me2 and decreases activation mark H3K9ac (<a href="/pmc/articles/PMC3731129/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3D</span></a>). These results suggest that PELP1-mediated genomic actions may play a role in PELP1 modulation of the expression and function of MMPs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3731129/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140566320125504"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f3.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f3.jpg" src="/pmc/articles/PMC3731129/bin/nihms343635f3.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140566320125504"><a target="object" rel="noopener" href="/pmc/articles/PMC3731129/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3731129/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p>PELP1 regulates the expression and activities of MMPs. A, gelatin zymography analysis of activity of MMP2 and MMP9 in SKOV3ip1 and ES2 cells that were transfected with control siRNA (con si) or PELP1-siRNA (PELP1-si). B, SKOV3ip1 and ES2 cells transfected with MMP9-Luc and MMP2-Luc vectors, treated with control siRNA or PELP1-siRNA, and the reporter gene activity was measured after 72 hours. C, ChIP assay was done using the DNA isolated from SKOV3ip1 cells and by using antibodies specific for PELP1 or isotype rabbit IgG control. DNA recovered from ChIP or input controls was subjected to real-time qPCR using 4 primers (A, B, C, and D) that span the MMP9 promoter region. D, SKOV3ip1 cells were transfected with control or PELP1-siRNA and ChIP assay was done using antibodies specific for H3K9Ac or H3K9me2. DNA recovered from ChIP or input controls was subjected to real-time qPCR using primers that detect proximal MMP9 promoter region. The promoter occupancy was calculated on the basis of the ratio of ChIP/input control. **, <em>P</em> &#x02264; 0.001, <em>t</em> test. NS, nonsignificant.</p></div></div></div></div><div id="S22" class="sec"><h3 id="S22title">PELP1 is involved in ovarian epithelial cell migration and invasion</h3><p id="P23" class="p p-first-last">To examine further whether overexpression of PELP1 in IOSE cells increases their migratory potential, we studied IOSE cells overexpressing PELP1 in a Boyden chamber assay. Overexpression of PELP1 substantially enhanced the migratory potential of IOSE cells (<a href="/pmc/articles/PMC3731129/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>). On the other hand, compared with control cells, PELP1 knockdown in SKOV3ip1 cells resulted in a significantly reduced migration in Boyden chamber assays (<a href="/pmc/articles/PMC3731129/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B</span></a>, left). Similarly, ES2-PELP1 knockdown cells also revealed significantly less migration (<a href="/pmc/articles/PMC3731129/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4C</span></a>, right). PELP1 knockdown also significantly reduced the invasion potential of both SKOVip1 and ES2 cells (<a href="/pmc/articles/PMC3731129/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4C</span></a>). Collectively, these results suggest that PELP1 has potential to modulate the expression of the genes that are involved in migratory and invasion potential of ovarian epithelial cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3731129/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140566316638032"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f4.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f4.jpg" src="/pmc/articles/PMC3731129/bin/nihms343635f4.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140566316638032"><a target="object" rel="noopener" href="/pmc/articles/PMC3731129/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3731129/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p>PELP1 knockdown affects the migration and invasion of ovarian cancer cells. A, migratory potential of IOSE cells overexpressing control vector (vec) or PELP1 expression vector was analyzed by using a Boyden chamber assay. B, cell migration potential of SKOV3ip1 and ES2 cells transfected with control of PELP1-siRNA was analyzed by using a Boyden chamber assay. Photomicrographs of migrated cells in various treatments are shown. C, cell invasion potential of SKOV3ip1 and ES2 cells transfected with control of PELP1-siRNA was analyzed using Matrigel invasion chamber assays. Photomicrographs of invaded cells in various treatments are shown. Columns, mean from 3 independent experiments; bars, SEM. **, <em>P</em> &#x0003c; 0.001, <em>t</em> test. WT, wild-type.</p></div></div></div></div><div id="S23" class="sec sec-last"><h3 id="S23title">PELP1-siRNA reduce ovarian cancer cell growth <em>in vitro</em> and tumor progression <em>in vivo</em></h3><p id="P24" class="p p-first-last">We next examined whether PELP1 downregulation affects proliferation of ovarian cancer cells <em>in vitro</em> by using a CellTiter-Glo assay. PELP1-siRNA-transfected SKOV3ip1 and ES2 showed substantially reduced cellular proliferation compared with control siRNA-transfected cells (<a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5A</span></a>). We then examined whether systemically administered PELP1-siRNA in a nanoliposomal formulation (PELP1-siRNA-DOPC) reduced tumor growth by using an ovarian cancer xenograft model. Nude mice were injected with SKOV3ip1 ovarian cancer cells (1 &#x000d7; 10<sup>6</sup> cells i.p). One week later, mice (<em>n</em> = 8/group) were randomly assigned to receive therapy with either 150 &#x003bc;g/kg control siRNA-DOPC or PELP1-siRNA-DOPC every 3 days, based on our previous dose&#x02013;response experiments for effective downregulation of genes <em>in vivo</em> (<a href="#R26" rid="R26" class=" bibr popnode">26</a>). After 27 days, mice were euthanized. IHC examination of the tumors revealed that PELP1-siRNA-DOPC&#x02013;treated tumors had low expression of PELP1 (<a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5B</span></a>). No toxicity was observed in behavioral changes, including eating habits and mobility, in animals treated with liposomes and mouse weights were not significantly different between control and PELP1-siRNA treatment groups (<a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a>). Compared with control siRNA-DOPC&#x02013;treated mice, nude mice treated with PELP1-siRNA-DOPC had a significant reduction in metastatic tumor nodules (54%, <em>P</em> &#x0003c; 0.001), a reduction in tumor growth (51%, <em>P</em> &#x0003c; 0.001), and reduction in ascites volume (84%, <em>P</em> &#x0003c; 0.001; <a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a>). PCNA staining of the tumor sections revealed a reduction in the proliferation in the PELP1-siRNA-DOPC&#x02013;treated tumors and 60% of cells in control siRNA&#x02013;treated tumors were PCNA positive, whereas only 20% of cells were PCNA positive in PELP1-siRNA&#x02013;treated tumors. (<a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5D</span></a>). TUNEL assay results showed increased apoptosis in PELP1-siRNA&#x02013;treated cells compared with control siRNA. PELP1-siRNA-DOPC&#x02013;treated tumors also had lower expression of MMP9 than the control tumors (<a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5D</span></a>). Collectively, these results suggest that PELP1 downregulation decreases tumor cell proliferation and increases apoptosis and that PELP1-siRNA-DOPC can be used therapeutically for reducing ovarian cancer growth <em>in vivo</em>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3731129/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140566309714672"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f5.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms343635f5.jpg" src="/pmc/articles/PMC3731129/bin/nihms343635f5.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140566309714672"><a target="object" rel="noopener" href="/pmc/articles/PMC3731129/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3731129/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p>PELP1-siRNA reduce ovarian cancer cell growth <em>in vitro</em> and tumor progression <em>in vivo.</em> A, cell proliferation capacity of SKOV3ip1 and ES2 cells were analyzed after treating the cells with control or PELP1-siRNA using CellTiter-Glo assay. B, IHC analysis of PELP1 expression in tumors treated with control or PELP1-siRNA liposomes. C, number of tumor nodules, mean tumor weight (mg), and ascites volume (ml) in control siRNA-DOPC- or PELP1-siRNADOPC-treated groups (<em>n</em> = 8/group). Column, mean tumor weights (g); bars, SEM. *, <em>P</em> &#x02264; 0.05; **, <em>P</em> &#x02264; 0.001, <em>t</em> test. D, PCNA expression as a marker of proliferation, TUNEL staining as a marker of apoptosis, and MMP9 expression was analyzed by immunohistochemistry in tumors (<em>n</em> = 8/group) treated with control or PELP1-siRNA-DOPC; quantitation was done as described in the &#x0201c;Materials and Methods&#x0201d; section; bars, SEM. **, <em>P</em> &#x0003c; 0.001.</p></div></div></div></div></div><div id="S24" class="tsec sec"><h2 class="head no_bottom_margin" id="S24title">Discussion</h2><p id="P25" class="p p-first">Among the gynecologic malignancies reported for Western countries, ovarian cancer has the highest mortality rate and is the most common (<a href="#R32" rid="R32" class=" bibr popnode">32</a>). Despite modest improvements in response rates, overall survival rates remain disappointing for patients with advanced ovarian cancer (<a href="#R33" rid="R33" class=" bibr popnode">33</a>). A widely recognized behavior of ovarian cancer is its ability to migrate and seed the peritoneal cavity with nests of tumor cells and the formation of ascites (<a href="#R4" rid="R4" class=" bibr popnode">4</a>). We found that (i) PELP1 plays a role in ovarian tumor cell cytoskeletal reorganization, (ii) PELP1 downregulation affects expression of genes involved in metastasis, (iii) PELP1 is recruited to promoters of MMPs and is required for optimal activation of MMPs, (iv) PELP1 overexpression in normal IOSE cells promote cell migration, (v) PELP1 knockdown substantially affected ovarian cancer ability to migrate in Boyden chamber and invasion assays, and (vi) downregulation of PELP1 <em>in vivo</em> by PELP1-siRNA-DOPC significantly reduced ovarian tumor progression in xenograft models. Collectively, these results suggest that PELP1 signaling confers growth and metastatic advantages to ovarian epithelial cells.</p><p id="P26">Even though individual proto-oncogenes may play a role in oncogenesis, master regulators that control activities of multiple oncogenes and NRs can provide a growth advantage to cancer cells. Emerging findings suggest that NR coregulator proteins have the potential to be differentially expressed in malignant tumors, and that their functions may be altered, leading to tumor progression (<a href="#R7" rid="R7" class=" bibr popnode">7</a>). A few recent studies examined the status of NR coregulators in ovarian tumors and found deregulation of a few coregulators including AIB1, SRA, and ARA70 (<a href="#R34" rid="R34" class=" bibr popnode">34</a>&#x02013;<a href="#R36" rid="R36" class=" bibr popnode">36</a>). Furthermore, AIB1 knockout mice studies demonstrated that normal expression of the coregulator AIB1 is required for initiation of tumorigenesis by carcinogens and oncogenes (<a href="#R37" rid="R37" class=" bibr popnode">37</a>, <a href="#R38" rid="R38" class=" bibr popnode">38</a>), suggesting that coregulators can play a vital role in tumor initiation and/or progression. PELP1 is a unique NR coregulator that interacts with a number of NRs (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). Its expression is deregulated in ovarian cancers (<a href="#R20" rid="R20" class=" bibr popnode">20</a>). Using a metastasis array, we have identified a close linkage between PELP1 expression in ovarian cells with the activation of many genes that are implicated in metastasis. Our results suggest that PELP1 is a central NR coregulator that plays a critical role in ovarian cancer progression and metastasis.</p><p id="P27">A number of oncogenes that allow cells to grow independently from the host signals have been identified in ovarian cancer. The proto-oncogene <em>c-Src</em> is of interest in ovarian tumors as overexpression of Src has been demonstrated in 93% of advanced-stage ovarian tumors (<a href="#R39" rid="R39" class=" bibr popnode">39</a>) and inhibition of c-Src in preclinical models can inhibit ovarian tumor growth (<a href="#R40" rid="R40" class=" bibr popnode">40</a>). Disruptions of the p16-CDK4/cyclin D1-pRb pathway (RB pathway) also play an important role in the development of ovarian cancers (<a href="#R41" rid="R41" class=" bibr popnode">41</a>). PELP1 couples NR signaling to cell-cycle progression via the pRb pathway (<a href="#R12" rid="R12" class=" bibr popnode">12</a>) and PELP1 is a recently identified substrate of cyclin-dependent kinases (CDK; <a href="#R24" rid="R24" class=" bibr popnode">ref. 24</a>). Emerging evidence suggests that <em>PELP1</em> is a proto-oncogene (<a href="#R14" rid="R14" class=" bibr popnode">14</a>) and collaborates with activation of other oncogenes including Src (<a href="#R11" rid="R11" class=" bibr popnode">11</a>). Growth factor and hormonal signals promote PELP1 interactions with cytosolic kinases leading to activation of MAPK (mitogen-activated protein kinase) and AKT pathways. Our results that PELP1 knockdown substantially affects the growth of ovarian cancer cells <em>in vitro</em> and <em>in vivo</em> also supports a role of PELP1 in providing growth advantage to ovarian cancer cells. PELP1-mediated crosstalk with cytosolic kinases and cell-cycle proteins may provide growth advantage in PELP1 deregulated ovarian cancer cells.</p><p id="P28">Accumulating evidence suggest that PELP1 functions as a large scaffolding protein and modulates gene transcription via protein&#x02013;protein interactions with histone-modifying acetylases/deacetylases (<a href="#R42" rid="R42" class=" bibr popnode">42</a>) and methyltransferases/demethylases. A recent study identified PELP1 as a component of the MLL1 methyltransferase complex (<a href="#R43" rid="R43" class=" bibr popnode">43</a>). We found that PELP1 functions as a modifier of dimethyl modification of histones (<a href="#R29" rid="R29" class=" bibr popnode">29</a>). Our results from the current study demonstrated that PELP1 signaling affects the ovarian cancer cell cytoskeleton and their migration. Gene array and expression analyses found that PELP1 has the potential to activate the transcription of genes involved in metastasis. ChIP studies revealed that PELP1 is recruited to the proximal promoter region of MMM9 and PELP1 knockdown enhances repressive mark H3K9me2 and decreases activation mark H3K9ac at the proximal promoter. These results suggest that PELP1-mediated genomic functions play a role in expression of genes involved in metastasis.</p><p id="P29">Currently, no known drugs inhibit PELP1 functions. Therefore, in this study, we developed PELP1-siRNA nanoliposomes to examine the <em>in vivo</em> therapeutic potential of inhibiting PELP1. We examined the ability of systemically administered PELP1-siRNA to silence <em>PELP1</em> gene expression <em>in vivo</em> using a xenograft model. The advantage of DOPC nanoliposomes is that they have no electrical charge. This neutrality provides an advantage over positively or negatively charged liposomes when it comes to binding with and penetrating cells (<a href="#R28" rid="R28" class=" bibr popnode">28</a>). Another advantage of DOPC nanoliposomes is their small size (65&#x02013;125 nm) that enables their transport through blood vessels. Several recently published studies validated <em>in vivo</em> delivery of siRNA using DOPC-based liposomes and proved that this method is therapeutically efficacious (<a href="#R26" rid="R26" class=" bibr popnode">26</a>, <a href="#R44" rid="R44" class=" bibr popnode">44</a>, <a href="#R45" rid="R45" class=" bibr popnode">45</a>). We found that PELP1-siRNA-DOPC can effectively reduce PELP1 expression and significantly reduced the tumor growth in ovarian xenografts. Peritoneal surfaces are the most common site of ovarian metastases. The reduction in the number of tumor nodules found in the PELP1-siRNA-DOPC&#x02013;treated nude mice indicate that PELP1-siRNA-DOPC has potential to block ovarian metastasis. These results suggest that PELP1-siRNA-DOPC can be used as a novel drug for therapeutic targeting of PELP1 in ovarian cancer.</p><p id="P30" class="p p-last">In summary, our results demonstrate that the NR coregulator PELP1 plays a critical role in ovarian cancer cell migration and modulates expression of several genes involved in metastasis. Even through earlier studies found that PELP1 plays a role in the proliferation of hormone-driven tumors, this study demonstrated that it also has the potential to promote metastasis of ovarian epithelial cells. Furthermore, our study results provide the first <em>in vivo</em> evidence that PELP1-siRNA-DOPC can be used as a line of therapy in ovarian cancer metastasis. Since multiple signaling pathways are involved in optimal generation of biological outcomes, targeting master regulators, such as PELP1, is clinically relevant and will have better therapeutic effect.</p></div><div id="unreferenced-ft" class="tsec sec"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="caption-a.j.f.atitle">Translational Relevance</h3></div><p id="P31">Ovarian carcinoma is the leading cause of death due to gynecologic malignancy. In this study, we investigated whether PELP1 (proline-, glutamic acid-, leucine-rich protein-1) signaling plays a role in ovarian epithelial cancer cell migration/metastasis and determined the therapeutic potential of PELP1-siRNA in vivo using a nanoliposomal formulation of PELP1-siRNA-DOPC (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine). Our results demonstrate that PELP1 plays a critical role in ovarian cancer cell migration and modulates expression of several genes involved in metastasis. We found that PELP1-siRNA-DOPC can effectively reduce PELP1 expression and significantly reduce the tumor growth in ovarian xenografts. The results suggest that PELP1 signaling axis is a potential druggable target and liposomal PELP1-siRNA-DOPC could be used as a novel drug to prevent or treat ovarian metastasis.</p></div></div></div><div id="S25" class="tsec sec"><h2 class="head no_bottom_margin" id="S25title">Acknowledgments</h2><div class="sec"><p><strong>Grant Support:</strong> This study was supported by NIH-CA0095681, W81XWH-06-1-0398, CTRC P30CA54174, U54CA151668, CA083639, and OCRF grants.</p></div></div><div id="fn-group-a.i.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.i.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"> <p class="p p-first-last"><strong>Disclosure of Potential Conflicts of Interest:</strong> No potential conflicts of interest were disclosed.</p></p></div></div><div id="ref-list-a.i.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.i.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Landen CN, Jr, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:995–1005.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18195328" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Early+events+in+the+pathogenesis+of+epithelial+ovarian+cancer&amp;author=CN+Landen&amp;author=MJ+Birrer&amp;author=AK+Sood&amp;volume=26&amp;publication_year=2008&amp;pages=995-1005&amp;pmid=18195328&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, et al. Focus on epithelial ovarian cancer. <span><span class="ref-journal">Cancer Cell. </span>2004;<span class="ref-vol">5</span>:19–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14749123" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=Focus+on+epithelial+ovarian+cancer&amp;author=RF+Ozols&amp;author=MA+Bookman&amp;author=DC+Connolly&amp;author=MB+Daly&amp;author=AK+Godwin&amp;volume=5&amp;publication_year=2004&amp;pages=19-24&amp;pmid=14749123&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Ozols RF. Systemic therapy for ovarian cancer: current status and new treatments. <span><span class="ref-journal">Semin Oncol. </span>2006;<span class="ref-vol">33</span>:S3–11.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16716797" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Oncol&amp;title=Systemic+therapy+for+ovarian+cancer:+current+status+and+new+treatments&amp;author=RF+Ozols&amp;volume=33&amp;publication_year=2006&amp;pages=S3-11&amp;pmid=16716797&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. <span><span class="ref-journal">Nat Rev Cancer. </span>2005;<span class="ref-vol">5</span>:355–66.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15864277" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Ovarian+cancer+metastasis:+integrating+insights+from+disparate+model+organisms&amp;author=H+Naora&amp;author=DJ+Montell&amp;volume=5&amp;publication_year=2005&amp;pages=355-66&amp;pmid=15864277&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">296</span>:1642–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12040178" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Connections+and+regulation+of+the+human+estrogen+receptor&amp;author=DP+McDonnell&amp;author=JD+Norris&amp;volume=296&amp;publication_year=2002&amp;pages=1642-4&amp;pmid=12040178&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. <span><span class="ref-journal">Endocr Rev. </span>1999;<span class="ref-vol">20</span>:321–44.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10368774" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Nuclear+receptor+coregulators:+cellular+and+molecular+biology&amp;author=NJ+McKenna&amp;author=RB+Lanz&amp;author=BW+O'Malley&amp;volume=20&amp;publication_year=1999&amp;pages=321-44&amp;pmid=10368774&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">O'Malley BW. Molecular biology. Little molecules with big goals. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">313</span>:1749–50.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16990541" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Molecular+biology.+Little+molecules+with+big+goals&amp;author=BW+O'Malley&amp;volume=313&amp;publication_year=2006&amp;pages=1749-50&amp;pmid=16990541&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. <span><span class="ref-journal">Genes Dev. </span>2006;<span class="ref-vol">20</span>:1405–28.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16751179" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;title=Sensors+and+signals:+a+coactivator/corepressor/epigenetic+code+for+integrating+signal-dependent+programs+of+transcriptional+response&amp;author=MG+Rosenfeld&amp;author=VV+Lunyak&amp;author=CK+Glass&amp;volume=20&amp;publication_year=2006&amp;pages=1405-28&amp;pmid=16751179&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">O'Malley BW. Coregulators: from whence came these &#x0201c;master genes&#x0201d; <span><span class="ref-journal">Mol Endocrinol. </span>2007;<span class="ref-vol">21</span>:1009–13.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17284664" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Coregulators:+from+whence+came+these+&#x0201c;master+genes&#x0201d;&amp;author=BW+O'Malley&amp;volume=21&amp;publication_year=2007&amp;pages=1009-13&amp;pmid=17284664&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A, et al. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:38272–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11481323" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Molecular+cloning+and+characterization+of+PELP1,+a+novel+human+coregulator+of+estrogen+receptor+alpha&amp;author=RK+Vadlamudi&amp;author=RA+Wang&amp;author=A+Mazumdar&amp;author=Y+Kim&amp;author=J+Shin&amp;volume=276&amp;publication_year=2001&amp;pages=38272-9&amp;pmid=11481323&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Vadlamudi RK, Kumar R. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR. <span><span class="ref-journal">Nucl Recept Signal. </span>2007;<span class="ref-vol">5</span>:e004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1876599/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17525794" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucl+Recept+Signal&amp;title=Functional+and+biological+properties+of+the+nuclear+receptor+coregulator+PELP1/MNAR&amp;author=RK+Vadlamudi&amp;author=R+Kumar&amp;volume=5&amp;publication_year=2007&amp;pages=e004&amp;pmid=17525794&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Balasenthil S, Vadlamudi RK. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:22119–27.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1262660/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12682072" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Functional+interactions+between+the+estrogen+receptor+coactivator+PELP1/MNAR+and+retinoblastoma+protein&amp;author=S+Balasenthil&amp;author=RK+Vadlamudi&amp;volume=278&amp;publication_year=2003&amp;pages=22119-27&amp;pmid=12682072&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. <span><span class="ref-journal">Cancer Res. </span>2004;<span class="ref-vol">64</span>:6416–23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15374949" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Potential+role+of+a+novel+transcriptional+coactivator+PELP1+in+histone+H1+displacement+in+cancer+cells&amp;author=SS+Nair&amp;author=SK+Mishra&amp;author=Z+Yang&amp;author=S+Balasenthil&amp;author=R+Kumar&amp;volume=64&amp;publication_year=2004&amp;pages=6416-23&amp;pmid=15374949&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Rajhans R, Nair S, Holden AH, Kumar R, Tekmal RR, Vadlamudi RK. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>:5505–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2774841/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17545633" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Oncogenic+potential+of+the+nuclear+receptor+coregulator+proline-,+glutamic+acid-,+leucine-rich+protein+1/modulator+of+the+nongenomic+actions+of+the+estrogen+receptor&amp;author=R+Rajhans&amp;author=S+Nair&amp;author=AH+Holden&amp;author=R+Kumar&amp;author=RR+Tekmal&amp;volume=67&amp;publication_year=2007&amp;pages=5505-12&amp;pmid=17545633&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Vadlamudi RK, Balasenthil S, Broaddus RR, Gustafsson JA, Kumar R. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004;<span class="ref-vol">89</span>:6130–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1262662/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15579769" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Deregulation+of+estrogen+receptor+coactivator+proline-,+glutamic+acid-,+and+leucine-rich+protein-1/modulator+of+nongenomic+activity+of+estrogen+receptor+in+human+endometrial+tumors&amp;author=RK+Vadlamudi&amp;author=S+Balasenthil&amp;author=RR+Broaddus&amp;author=JA+Gustafsson&amp;author=R+Kumar&amp;volume=89&amp;publication_year=2004&amp;pages=6130-8&amp;pmid=15579769&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Habashy HO, Powe DG, Rakha EA, Ball G, Macmillan RD, Green AR, et al. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2010;<span class="ref-vol">120</span>:603–12.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19495959" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=The+prognostic+significance+of+PELP1+expression+in+invasive+breast+cancer+with+emphasis+on+the+ER-positive+luminal-like+subtype&amp;author=HO+Habashy&amp;author=DG+Powe&amp;author=EA+Rakha&amp;author=G+Ball&amp;author=RD+Macmillan&amp;volume=120&amp;publication_year=2010&amp;pages=603-12&amp;pmid=19495959&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Nair S, Vadlamudi RK. Emerging significance of ER-coregulator PELP1/MNAR in cancer. <span><span class="ref-journal">Histol Histopathol. </span>2007;<span class="ref-vol">22</span>:91–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2782660/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17128415" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Histol+Histopathol&amp;title=Emerging+significance+of+ER-coregulator+PELP1/MNAR+in+cancer&amp;author=S+Nair&amp;author=RK+Vadlamudi&amp;volume=22&amp;publication_year=2007&amp;pages=91-6&amp;pmid=17128415&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. <span><span class="ref-journal">J Natl Cancer Inst. </span>1998;<span class="ref-vol">90</span>:447–54.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9521169" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Expression+of+angiogenesis-related+genes+and+progression+of+human+ovarian+carcinomas+in+nude+mice&amp;author=J+Yoneda&amp;author=H+Kuniyasu&amp;author=MA+Crispens&amp;author=JE+Price&amp;author=CD+Bucana&amp;volume=90&amp;publication_year=1998&amp;pages=447-54&amp;pmid=9521169&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Choi KC, Auersperg N, Leung PC. Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2001;<span class="ref-vol">86</span>:5075–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11600588" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Expression+and+antiproliferative+effect+of+a+second+form+of+gonadotropin-releasing+hormone+in+normal+and+neoplastic+ovarian+surface+epithelial+cells&amp;author=KC+Choi&amp;author=N+Auersperg&amp;author=PC+Leung&amp;volume=86&amp;publication_year=2001&amp;pages=5075-8&amp;pmid=11600588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, et al. Role of PELP1/MNAR signaling in ovarian tumorigenesis. <span><span class="ref-journal">Cancer Res. </span>2008;<span class="ref-vol">68</span>:4902–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18559538" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Role+of+PELP1/MNAR+signaling+in+ovarian+tumorigenesis&amp;author=C+Dimple&amp;author=SS+Nair&amp;author=R+Rajhans&amp;author=PR+Pitcheswara&amp;author=J+Liu&amp;volume=68&amp;publication_year=2008&amp;pages=4902-9&amp;pmid=18559538&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, et al. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. <span><span class="ref-journal">Cancer Res. </span>2010;<span class="ref-vol">70</span>:4092–101.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2889925/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20460518" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Extranuclear+functions+of+ER+impact+invasive+migration+and+metastasis+by+breast+cancer+cells&amp;author=D+Chakravarty&amp;author=SS+Nair&amp;author=B+Santhamma&amp;author=BC+Nair&amp;author=L+Wang&amp;volume=70&amp;publication_year=2010&amp;pages=4092-101&amp;pmid=20460518&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Qin L, Liao L, Redmond A, Young L, Yuan Y, Chen H, et al. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-medicated matrix metalloproteinase 2 (MMP2) and MMP9 expression. <span><span class="ref-journal">Mol Cell Biol. </span>2008;<span class="ref-vol">28</span>:5937–50.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2547002/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18644862" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=The+AIB1+oncogene+promotes+breast+cancer+metastasis+by+activation+of+PEA3-medicated+matrix+metalloproteinase+2+(MMP2)+and+MMP9+expression&amp;author=L+Qin&amp;author=L+Liao&amp;author=A+Redmond&amp;author=L+Young&amp;author=Y+Yuan&amp;volume=28&amp;publication_year=2008&amp;pages=5937-50&amp;pmid=18644862&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:29130–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10506168" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+transcription+factors+Sp1,+Sp3,+and+AP-2+are+required+for+constitutive+matrix+metalloproteinase-2+gene+expression+in+astroglioma+cells&amp;author=H+Qin&amp;author=Y+Sun&amp;author=EN+Benveniste&amp;volume=274&amp;publication_year=1999&amp;pages=29130-7&amp;pmid=10506168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Nair BC, Nair SS, Chakravarty D, Challa R, Manavathi B, Yew PR, et al. Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1. <span><span class="ref-journal">Cancer Res. </span>2010;<span class="ref-vol">70</span>:7166–75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3058498/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20807815" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Cyclin-dependent+kinase-mediated+phosphorylation+plays+a+critical+role+in+the+oncogenic+functions+of+PELP1&amp;author=BC+Nair&amp;author=SS+Nair&amp;author=D+Chakravarty&amp;author=R+Challa&amp;author=B+Manavathi&amp;volume=70&amp;publication_year=2010&amp;pages=7166-75&amp;pmid=20807815&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Lengyel E, Gum R, Juarez J, Clayman G, Seiki M, Sato H, et al. Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. <span><span class="ref-journal">Cancer Res. </span>1995;<span class="ref-vol">55</span>:963–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7850814" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Induction+of+M(r)+92,000+type+IV+collagenase+expression+in+a+squamous+cell+carcinoma+cell+line+by+fibroblasts&amp;author=E+Lengyel&amp;author=R+Gum&amp;author=J+Juarez&amp;author=G+Clayman&amp;author=M+Seiki&amp;volume=55&amp;publication_year=1995&amp;pages=963-7&amp;pmid=7850814&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Landen CN, Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, et al. Therapeutic EphA2 gene targeting <em>in vivo</em> using neutral liposomal small interfering RNA delivery. <span><span class="ref-journal">Cancer Res. </span>2005;<span class="ref-vol">65</span>:6910–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16061675" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Therapeutic+EphA2+gene+targeting+in+vivo+using+neutral+liposomal+small+interfering+RNA+delivery&amp;author=CN+Landen&amp;author=A+Chavez-Reyes&amp;author=C+Bucana&amp;author=R+Schmandt&amp;author=MT+Deavers&amp;volume=65&amp;publication_year=2005&amp;pages=6910-8&amp;pmid=16061675&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, et al. Therapeutic targeting of ATP7B in ovarian carcinoma. <span><span class="ref-journal">Clin Cancer Res. </span>2009;<span class="ref-vol">15</span>:3770–80.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2752981/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19470734" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Therapeutic+targeting+of+ATP7B+in+ovarian+carcinoma&amp;author=LS+Mangala&amp;author=V+Zuzel&amp;author=R+Schmandt&amp;author=ES+Leshane&amp;author=JB+Halder&amp;volume=15&amp;publication_year=2009&amp;pages=3770-80&amp;pmid=19470734&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span><link class="expression-of-concern" pmcaccid="0" /></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. <span><span class="ref-journal">Cancer Metastasis Rev. </span>1998;<span class="ref-vol">17</span>:279–84.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10352881" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Metastasis+Rev&amp;title=Orthotopic+models+are+necessary+to+predict+therapy+of+transplantable+tumors+in+mice&amp;author=JJ+Killion&amp;author=R+Radinsky&amp;author=IJ+Fidler&amp;volume=17&amp;publication_year=1998&amp;pages=279-84&amp;pmid=10352881&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Nair SS, Nair BC, Cortez V, Chakravarty D, Metzger E, Sch&#x000fc;le R, et al. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. <span><span class="ref-journal">EMBO Rep. </span>2010;<span class="ref-vol">11</span>:438–44.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2892318/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20448663" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+Rep&amp;title=PELP1+is+a+reader+of+histone+H3+methylation+that+facilitates+oestrogen+receptor-alpha+target+gene+activation+by+regulating+lysine+demethylase+1+specificity&amp;author=SS+Nair&amp;author=BC+Nair&amp;author=V+Cortez&amp;author=D+Chakravarty&amp;author=E+Metzger&amp;volume=11&amp;publication_year=2010&amp;pages=438-44&amp;pmid=20448663&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Stack MS, Ellerbroek SM, Fishman DA. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. <span><span class="ref-journal">Int J Oncol. </span>1998;<span class="ref-vol">12</span>:569–76.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9472094" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;title=The+role+of+proteolytic+enzymes+in+the+pathology+of+epithelial+ovarian+carcinoma&amp;author=MS+Stack&amp;author=SM+Ellerbroek&amp;author=DA+Fishman&amp;volume=12&amp;publication_year=1998&amp;pages=569-76&amp;pmid=9472094&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPS and their regulators in ovarian cancer. <span><span class="ref-journal">Int J Cancer. </span>1994;<span class="ref-vol">58</span>:50–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8014015" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Expression+and+activity+of+MMPS+and+their+regulators+in+ovarian+cancer&amp;author=MS+Naylor&amp;author=GW+Stamp&amp;author=BD+Davies&amp;author=FR+Balkwill&amp;volume=58&amp;publication_year=1994&amp;pages=50-6&amp;pmid=8014015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Perez RP, Godwin AK, Hamilton TC, Ozols RF. Ovarian cancer biology. <span><span class="ref-journal">Semin Oncol. </span>1991;<span class="ref-vol">18</span>:186–204.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2042060" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Oncol&amp;title=Ovarian+cancer+biology&amp;author=RP+Perez&amp;author=AK+Godwin&amp;author=TC+Hamilton&amp;author=RF+Ozols&amp;volume=18&amp;publication_year=1991&amp;pages=186-204&amp;pmid=2042060&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. <span><span class="ref-journal">Endocr Rev. </span>2001;<span class="ref-vol">22</span>:255–88.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11294827" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Ovarian+surface+epithelium:+biology,+endocrinology,+and+pathology&amp;author=N+Auersperg&amp;author=AS+Wong&amp;author=KC+Choi&amp;author=SK+Kang&amp;author=PC+Leung&amp;volume=22&amp;publication_year=2001&amp;pages=255-88&amp;pmid=11294827&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. <span><span class="ref-journal">Science. </span>1997;<span class="ref-vol">277</span>:965–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9252329" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=AIB1,+a+steroid+receptor+coactivator+amplified+in+breast+and+ovarian+cancer&amp;author=SL+Anzick&amp;author=J+Kononen&amp;author=RL+Walker&amp;author=DO+Azorsa&amp;author=MM+Tanner&amp;volume=277&amp;publication_year=1997&amp;pages=965-8&amp;pmid=9252329&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Li AJ, Lerner DL, Gapuzan ME, Karlan BY. AIB1 polymorphisms predict aggressive ovarian cancer phenotype. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2005;<span class="ref-vol">14</span>:2919–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16365010" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=AIB1+polymorphisms+predict+aggressive+ovarian+cancer+phenotype&amp;author=AJ+Li&amp;author=DL+Lerner&amp;author=ME+Gapuzan&amp;author=BY+Karlan&amp;volume=14&amp;publication_year=2005&amp;pages=2919-22&amp;pmid=16365010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Quezada S, Avellaira C, Johnson MC, Gabler F, Fuentes A, Vega M. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. <span><span class="ref-journal">Fertil Steril. </span>2006;<span class="ref-vol">85</span>:1017–26.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16580389" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Fertil+Steril&amp;title=Evaluation+of+steroid+receptors,+coregulators,+and+molecules+associated+with+uterine+receptivity+in+secretory+endometria+from+untreated+women+with+polycystic+ovary+syndrome&amp;author=S+Quezada&amp;author=C+Avellaira&amp;author=MC+Johnson&amp;author=F+Gabler&amp;author=A+Fuentes&amp;volume=85&amp;publication_year=2006&amp;pages=1017-26&amp;pmid=16580389&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Kuang SQ, Liao L, Wang S, Medina D, O'Malley BW, Xu J. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. <span><span class="ref-journal">Cancer Res. </span>2005;<span class="ref-vol">65</span>:7993–8002.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16140972" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Mice+lacking+the+amplified+in+breast+cancer+1/steroid+receptor+coactivator-3+are+resistant+to+chemical+carcinogen-induced+mammary+tumorigenesis&amp;author=SQ+Kuang&amp;author=L+Liao&amp;author=S+Wang&amp;author=D+Medina&amp;author=BW+O'Malley&amp;volume=65&amp;publication_year=2005&amp;pages=7993-8002&amp;pmid=16140972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Kuang SQ, Liao L, Zhang H, Lee AV, O'Malley BW, Xu J. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. <span><span class="ref-journal">Cancer Res. </span>2004;<span class="ref-vol">64</span>:1875–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14996752" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=AIB1/SRC-3+deficiency+affects+insulin-like+growth+factor+I+signaling+pathway+and+suppresses+v-Ha-ras-induced+breast+cancer+initiation+and+progression+in+mice&amp;author=SQ+Kuang&amp;author=L+Liao&amp;author=H+Zhang&amp;author=AV+Lee&amp;author=BW+O'Malley&amp;volume=64&amp;publication_year=2004&amp;pages=1875-85&amp;pmid=14996752&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, et al. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. <span><span class="ref-journal">Gynecol Oncol. </span>2003;<span class="ref-vol">88</span>:73–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12504632" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol+Oncol&amp;title=Activated+SRC+protein+tyrosine+kinase+is+overexpressed+in+late-stage+human+ovarian+cancers&amp;author=JR+Wiener&amp;author=TC+Windham&amp;author=VC+Estrella&amp;author=NU+Parikh&amp;author=PF+Thall&amp;volume=88&amp;publication_year=2003&amp;pages=73-9&amp;pmid=12504632&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Han LY, Landen CN, Trevino JG, Halder J, Lin YG, Kamat AA, et al. Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:8633–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3202609/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16951177" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Antiangiogenic+and+antitumor+effects+of+SRC+inhibition+in+ovarian+carcinoma&amp;author=LY+Han&amp;author=CN+Landen&amp;author=JG+Trevino&amp;author=J+Halder&amp;author=YG+Lin&amp;volume=66&amp;publication_year=2006&amp;pages=8633-9&amp;pmid=16951177&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Hashiguchi Y, Tsuda H, Yamamoto K, Inoue T, Ishiko O, Ogita S. Combined analysis of p53 and RB pathways in epithelial ovarian cancer. <span><span class="ref-journal">Hum Pathol. </span>2001;<span class="ref-vol">32</span>:988–96.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11567230" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Pathol&amp;title=Combined+analysis+of+p53+and+RB+pathways+in+epithelial+ovarian+cancer&amp;author=Y+Hashiguchi&amp;author=H+Tsuda&amp;author=K+Yamamoto&amp;author=T+Inoue&amp;author=O+Ishiko&amp;volume=32&amp;publication_year=2001&amp;pages=988-96&amp;pmid=11567230&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Choi YB, Ko JK, Shin J. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:50930–41.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15456770" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+transcriptional+corepressor,+PELP1,+recruits+HDAC2+and+masks+histones+using+two+separate+domains&amp;author=YB+Choi&amp;author=JK+Ko&amp;author=J+Shin&amp;volume=279&amp;publication_year=2004&amp;pages=50930-41&amp;pmid=15456770&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, Wysocka J, et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. <span><span class="ref-journal">Cell. </span>2005;<span class="ref-vol">121</span>:873–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15960975" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Physical+association+and+coordinate+function+of+the+H3+K4+methyltransferase+MLL1+and+the+H4+K16+acetyltransferase+MOF&amp;author=Y+Dou&amp;author=TA+Milne&amp;author=AJ+Tackett&amp;author=ER+Smith&amp;author=A+Fukuda&amp;volume=121&amp;publication_year=2005&amp;pages=873-85&amp;pmid=15960975&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Halder J, Kamat AA, Landen CN, Jr, Han LY, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:4916–24.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3144499/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16914580" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Focal+adhesion+kinase+targeting+using+in+vivo+short+interfering+RNA+delivery+in+neutral+liposomes+for+ovarian+carcinoma+therapy&amp;author=J+Halder&amp;author=AA+Kamat&amp;author=CN+Landen&amp;author=LY+Han&amp;author=SK+Lutgendorf&amp;volume=12&amp;publication_year=2006&amp;pages=4916-24&amp;pmid=16914580&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Landen CN, Merritt WM, Mangala LS, Sanguino AM, Bucana C, Lu C, et al. Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. <span><span class="ref-journal">Cancer Biol Ther. </span>2006;<span class="ref-vol">5</span>:1708–13.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17106249" ref="reftype=pubmed&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Intraperitoneal+delivery+of+liposomal+siRNA+for+therapy+of+advanced+ovarian+cancer&amp;author=CN+Landen&amp;author=WM+Merritt&amp;author=LS+Mangala&amp;author=AM+Sanguino&amp;author=C+Bucana&amp;volume=5&amp;publication_year=2006&amp;pages=1708-13&amp;pmid=17106249&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3731129&amp;issue-id=225813&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3731129/pdf/nihms343635.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3731129/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3731129/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3731129" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="9gXCx57b5FI6ndFADSJGHcd7lcaFKQ9WRrgImMOBUJSZSoTjGBsGsc9l4sSe5WtU">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F&amp;text=Therapeutic%20Targeting%20of%20PELP1%20Prevents%20Ovarian%20Cancer%20Growth%20and%20Metastasis" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3731129%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731129/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/21421858/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/21421858/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3731129/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3731129/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3731129/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
